Surmodics

News

SurModics future uncertain after CEO leaves drug delivery company

You certainly can’t accuse Bruce Barclay of standing still. Since SurModics Inc. (NASDAQ: SRDX) named Barclay CEO in 2005, Barclay has reorganized the drug company’s business units, purchased land, signed licensing agreements, acquired several companies and expanded into ophthalmology and drug development. Yet the company, based in Eden Prairie, Minn., still has little to show […]

News

Night Read (Minnesota): Possible deal to save GAMC

en. Linda Berglin, the chair of her chamber’s Health and Human Services Budget Division and the key legislative leader in the debate over GAMC, tells PIM the plan advanced on Monday by Rep. Matt Dean, R-Dellwood, is “less objectionable” than the auto-enrollment of former GAMC recipients in MinnesotaCare that the Pawlenty administration began to implement this week.

presented by